AOS vs ERNA · P/E 19, rev $3.83B vs P/E 0.0, rev $582.0K
Smith AO Corporation (AOS) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported AOS revenue for 2025-12-31 was $3.83B. Net income was $546.2M. Revenue was up 0.3% from 2024-12-31 to 2025-12-31. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the AOS and ERNA stock pages for the full models.
Not investment advice.